Structure

Physi-Chem Properties

Molecular Weight:  773.87
Volume:  524.604
LogP:  1.152
LogD:  2.555
LogS:  -3.628
# Rotatable Bonds:  9
TPSA:  200.64
# H-Bond Aceptor:  12
# H-Bond Donor:  10
# Rings:  5
# Heavy Atoms:  16

MedChem Properties

QED Drug-Likeness Score:  0.137
Synthetic Accessibility Score:  5.286
Fsp3:  0.273
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.882
MDCK Permeability:  1.6646466974634677e-05
Pgp-inhibitor:  0.995
Pgp-substrate:  0.999
Human Intestinal Absorption (HIA):  0.998
20% Bioavailability (F20%):  0.059
30% Bioavailability (F30%):  0.021

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.348
Plasma Protein Binding (PPB):  99.21581268310547%
Volume Distribution (VD):  0.633
Pgp-substrate:  4.084418773651123%

ADMET: Metabolism

CYP1A2-inhibitor:  0.097
CYP1A2-substrate:  0.907
CYP2C19-inhibitor:  0.785
CYP2C19-substrate:  0.018
CYP2C9-inhibitor:  0.679
CYP2C9-substrate:  0.001
CYP2D6-inhibitor:  0.0
CYP2D6-substrate:  0.01
CYP3A4-inhibitor:  0.943
CYP3A4-substrate:  0.179

ADMET: Excretion

Clearance (CL):  2.388
Half-life (T1/2):  0.898

ADMET: Toxicity

hERG Blockers:  0.987
Human Hepatotoxicity (H-HT):  0.997
Drug-inuced Liver Injury (DILI):  0.978
AMES Toxicity:  0.009
Rat Oral Acute Toxicity:  0.986
Maximum Recommended Daily Dose:  0.984
Skin Sensitization:  0.641
Carcinogencity:  0.358
Eye Corrosion:  0.003
Eye Irritation:  0.011
Respiratory Toxicity:  0.984

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469717

Natural Product ID:  NPC469717
Common Name*:   Dibromoageliferin
IUPAC Name:   N-[[(4R,5R,6S)-2-amino-4-(2-amino-1H-imidazol-5-yl)-6-[[(3,4-dibromo-1H-pyrrole-2-carbonyl)amino]methyl]-4,5,6,7-tetrahydro-1H-benzimidazol-5-yl]methyl]-4,5-dibromo-1H-pyrrole-2-carboxamide
Synonyms:   Dibromoageliferin
Standard InCHIKey:  GJJKGKKNMPQKHM-WFEFGEHDSA-N
Standard InCHI:  InChI=1S/C22H22Br4N10O2/c23-9-2-12(33-18(9)26)19(37)31-4-8-7(3-30-20(38)17-15(25)10(24)5-29-17)1-11-16(36-22(28)34-11)14(8)13-6-32-21(27)35-13/h2,5-8,14,29,33H,1,3-4H2,(H,30,38)(H,31,37)(H3,27,32,35)(H3,28,34,36)/t7-,8-,14-/m1/s1
SMILES:  C1C(C(C(C2=C1NC(=N2)N)C3=CN=C(N3)N)CNC(=O)C4=CC(=C(N4)Br)Br)CNC(=O)C5=C(C(=CN5)Br)Br
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1162476
PubChem CID:   44584345
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0001093] Carboxylic acid derivatives
          • [CHEMONTID:0000475] Carboxylic acid amides
            • [CHEMONTID:0004817] 2-heteroaryl carboxamides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32675 agelas sp. Species Agelasidae Eukaryota n.a. n.a. n.a. PMID[15332839]
NPO32675 agelas sp. Species Agelasidae Eukaryota n.a. n.a. n.a. PMID[16562840]
NPO32675 agelas sp. Species Agelasidae Eukaryota n.a. n.a. n.a. PMID[19209898]
NPO32675 agelas sp. Species Agelasidae Eukaryota n.a. n.a. n.a. PMID[9584409]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT729 Organism Micrococcus luteus Micrococcus luteus MIC = 2.08 ug.mL-1 PMID[502050]
NPT79 Organism Bacillus subtilis Bacillus subtilis MIC = 4.16 ug.mL-1 PMID[502050]
NPT19 Organism Escherichia coli Escherichia coli MIC = 16.7 ug.mL-1 PMID[502050]
NPT2 Others Unspecified IC50 > 50000.0 nM PMID[502050]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469717 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9119 High Similarity NPC136957
0.9119 High Similarity NPC19696
0.9016 High Similarity NPC475286
0.9016 High Similarity NPC174281
0.886 High Similarity NPC19342
0.8769 High Similarity NPC476526
0.8769 High Similarity NPC48117
0.8769 High Similarity NPC329765
0.855 High Similarity NPC9635
0.8549 High Similarity NPC111566
0.8505 High Similarity NPC310633
0.848 Intermediate Similarity NPC476524
0.8359 Intermediate Similarity NPC63571
0.8265 Intermediate Similarity NPC476527
0.8213 Intermediate Similarity NPC476525
0.7789 Intermediate Similarity NPC184932
0.7789 Intermediate Similarity NPC472861
0.7704 Intermediate Similarity NPC54214
0.7639 Intermediate Similarity NPC66642
0.763 Intermediate Similarity NPC469716
0.7629 Intermediate Similarity NPC206148
0.7573 Intermediate Similarity NPC210123
0.7537 Intermediate Similarity NPC469814
0.7487 Intermediate Similarity NPC271927
0.745 Intermediate Similarity NPC37268
0.7437 Intermediate Similarity NPC469976
0.7416 Intermediate Similarity NPC476414
0.7413 Intermediate Similarity NPC136441
0.74 Intermediate Similarity NPC80528
0.7389 Intermediate Similarity NPC40530
0.7389 Intermediate Similarity NPC314281
0.7368 Intermediate Similarity NPC476413
0.7325 Intermediate Similarity NPC156003
0.7309 Intermediate Similarity NPC475736
0.7286 Intermediate Similarity NPC474696
0.7273 Intermediate Similarity NPC476418
0.7273 Intermediate Similarity NPC73687
0.7264 Intermediate Similarity NPC28096
0.7264 Intermediate Similarity NPC476421
0.7264 Intermediate Similarity NPC227489
0.7192 Intermediate Similarity NPC97106
0.7178 Intermediate Similarity NPC226835
0.7129 Intermediate Similarity NPC46022
0.7129 Intermediate Similarity NPC112489
0.71 Intermediate Similarity NPC162268
0.7093 Intermediate Similarity NPC474195
0.7089 Intermediate Similarity NPC188821
0.7089 Intermediate Similarity NPC474180
0.7056 Intermediate Similarity NPC33229
0.7054 Intermediate Similarity NPC282247
0.7043 Intermediate Similarity NPC474196
0.7037 Intermediate Similarity NPC474389
0.7023 Intermediate Similarity NPC77061
0.7 Intermediate Similarity NPC473376
0.7 Intermediate Similarity NPC473706
0.699 Remote Similarity NPC52110
0.6987 Remote Similarity NPC17487
0.6987 Remote Similarity NPC201831
0.6985 Remote Similarity NPC475870
0.6978 Remote Similarity NPC470703
0.6977 Remote Similarity NPC46811
0.6958 Remote Similarity NPC477109
0.6958 Remote Similarity NPC477107
0.6958 Remote Similarity NPC477108
0.6933 Remote Similarity NPC470702
0.6933 Remote Similarity NPC473218
0.6919 Remote Similarity NPC311282
0.6905 Remote Similarity NPC270834
0.6889 Remote Similarity NPC82370
0.6884 Remote Similarity NPC304187
0.6884 Remote Similarity NPC477166
0.6883 Remote Similarity NPC243633
0.6883 Remote Similarity NPC175150
0.6881 Remote Similarity NPC171317
0.6877 Remote Similarity NPC117980
0.6855 Remote Similarity NPC475746
0.6851 Remote Similarity NPC69843
0.6849 Remote Similarity NPC477004
0.6845 Remote Similarity NPC302647
0.6826 Remote Similarity NPC168209
0.6816 Remote Similarity NPC27296
0.6816 Remote Similarity NPC212742
0.6814 Remote Similarity NPC320968
0.6812 Remote Similarity NPC472285
0.681 Remote Similarity NPC16659
0.6804 Remote Similarity NPC131887
0.68 Remote Similarity NPC474236
0.6794 Remote Similarity NPC240088
0.6794 Remote Similarity NPC473380
0.6784 Remote Similarity NPC469715
0.6776 Remote Similarity NPC17059
0.6762 Remote Similarity NPC265710
0.6761 Remote Similarity NPC476423
0.6761 Remote Similarity NPC471536
0.6758 Remote Similarity NPC74153
0.6754 Remote Similarity NPC54744
0.6751 Remote Similarity NPC470323
0.6744 Remote Similarity NPC213629
0.6732 Remote Similarity NPC474383
0.6711 Remote Similarity NPC471194
0.6711 Remote Similarity NPC471193
0.6709 Remote Similarity NPC229893
0.6705 Remote Similarity NPC77101
0.6701 Remote Similarity NPC260041
0.67 Remote Similarity NPC109158
0.6697 Remote Similarity NPC473821
0.6695 Remote Similarity NPC474357
0.6667 Remote Similarity NPC477114
0.6667 Remote Similarity NPC166209
0.6667 Remote Similarity NPC13456
0.6667 Remote Similarity NPC77241
0.6667 Remote Similarity NPC72956
0.6667 Remote Similarity NPC269203
0.6653 Remote Similarity NPC935
0.6653 Remote Similarity NPC63031
0.6653 Remote Similarity NPC267078
0.6652 Remote Similarity NPC50562
0.6652 Remote Similarity NPC272174
0.6651 Remote Similarity NPC94752
0.6651 Remote Similarity NPC473342
0.6651 Remote Similarity NPC477167
0.665 Remote Similarity NPC2414
0.6638 Remote Similarity NPC153980
0.6638 Remote Similarity NPC6865
0.6637 Remote Similarity NPC52909
0.6637 Remote Similarity NPC94211
0.6637 Remote Similarity NPC475935
0.6636 Remote Similarity NPC228835
0.6627 Remote Similarity NPC74619
0.6623 Remote Similarity NPC471192
0.6623 Remote Similarity NPC177996
0.6623 Remote Similarity NPC67658
0.6623 Remote Similarity NPC147983
0.6622 Remote Similarity NPC220797
0.6622 Remote Similarity NPC474318
0.6622 Remote Similarity NPC153123
0.6622 Remote Similarity NPC201266
0.6622 Remote Similarity NPC475914
0.6622 Remote Similarity NPC268744
0.6617 Remote Similarity NPC472260
0.6601 Remote Similarity NPC142688
0.6594 Remote Similarity NPC54981
0.6592 Remote Similarity NPC106771
0.6592 Remote Similarity NPC303820
0.6592 Remote Similarity NPC205254
0.6592 Remote Similarity NPC23420
0.659 Remote Similarity NPC209917
0.6588 Remote Similarity NPC476419
0.6577 Remote Similarity NPC321939
0.657 Remote Similarity NPC233380
0.6564 Remote Similarity NPC54420
0.6558 Remote Similarity NPC477003
0.6553 Remote Similarity NPC474896
0.6552 Remote Similarity NPC36405
0.6532 Remote Similarity NPC78767
0.6532 Remote Similarity NPC473814
0.6532 Remote Similarity NPC262898
0.653 Remote Similarity NPC476460
0.6529 Remote Similarity NPC174489
0.6529 Remote Similarity NPC475635
0.6528 Remote Similarity NPC150592
0.6525 Remote Similarity NPC31097
0.6516 Remote Similarity NPC93390
0.6515 Remote Similarity NPC279189
0.6515 Remote Similarity NPC200553
0.6507 Remote Similarity NPC107077
0.6507 Remote Similarity NPC223791
0.6507 Remote Similarity NPC162860
0.6504 Remote Similarity NPC171393
0.6504 Remote Similarity NPC295452
0.6504 Remote Similarity NPC317701
0.6502 Remote Similarity NPC162002
0.6502 Remote Similarity NPC473640
0.6489 Remote Similarity NPC475506
0.6489 Remote Similarity NPC300183
0.6489 Remote Similarity NPC471944
0.6486 Remote Similarity NPC179701
0.648 Remote Similarity NPC477630
0.648 Remote Similarity NPC477635
0.6475 Remote Similarity NPC26641
0.6473 Remote Similarity NPC293917
0.6473 Remote Similarity NPC100321
0.6473 Remote Similarity NPC253687
0.6463 Remote Similarity NPC116555
0.6463 Remote Similarity NPC71238
0.646 Remote Similarity NPC155143
0.6459 Remote Similarity NPC49217
0.6457 Remote Similarity NPC63109
0.6455 Remote Similarity NPC243716
0.6449 Remote Similarity NPC11126
0.6446 Remote Similarity NPC89987
0.6442 Remote Similarity NPC306160
0.6438 Remote Similarity NPC473628
0.6429 Remote Similarity NPC64216
0.6426 Remote Similarity NPC264285
0.6423 Remote Similarity NPC37152
0.6417 Remote Similarity NPC323244
0.6414 Remote Similarity NPC473317
0.6409 Remote Similarity NPC83111
0.6409 Remote Similarity NPC475874

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469717 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.7358 Intermediate Similarity NPD7459 Phase 2
0.7184 Intermediate Similarity NPD3178 Discontinued
0.7033 Intermediate Similarity NPD1096 Discontinued
0.7014 Intermediate Similarity NPD8493 Clinical (unspecified phase)
0.6938 Remote Similarity NPD1783 Clinical (unspecified phase)
0.6866 Remote Similarity NPD2289 Phase 3
0.6866 Remote Similarity NPD2290 Phase 3
0.6784 Remote Similarity NPD3917 Approved
0.6784 Remote Similarity NPD3916 Clinical (unspecified phase)
0.6784 Remote Similarity NPD3918 Approved
0.6781 Remote Similarity NPD6753 Phase 1
0.6781 Remote Similarity NPD6752 Phase 1
0.674 Remote Similarity NPD3915 Approved
0.6729 Remote Similarity NPD706 Phase 1
0.6725 Remote Similarity NPD7971 Clinical (unspecified phase)
0.6725 Remote Similarity NPD7970 Approved
0.6712 Remote Similarity NPD5017 Discontinued
0.6695 Remote Similarity NPD6165 Phase 2
0.6695 Remote Similarity NPD6164 Phase 2
0.6667 Remote Similarity NPD4559 Clinical (unspecified phase)
0.6623 Remote Similarity NPD3353 Approved
0.6623 Remote Similarity NPD7809 Clinical (unspecified phase)
0.6606 Remote Similarity NPD5592 Clinical (unspecified phase)
0.6595 Remote Similarity NPD2813 Phase 3
0.6595 Remote Similarity NPD2812 Clinical (unspecified phase)
0.6581 Remote Similarity NPD1996 Discontinued
0.6522 Remote Similarity NPD7470 Discontinued
0.6507 Remote Similarity NPD7704 Clinical (unspecified phase)
0.6491 Remote Similarity NPD3411 Phase 2
0.6491 Remote Similarity NPD3410 Approved
0.6485 Remote Similarity NPD8292 Phase 2
0.6484 Remote Similarity NPD5686 Approved
0.6484 Remote Similarity NPD5685 Approved
0.6473 Remote Similarity NPD7621 Clinical (unspecified phase)
0.6471 Remote Similarity NPD460 Discontinued
0.6463 Remote Similarity NPD2443 Approved
0.6463 Remote Similarity NPD2442 Approved
0.6452 Remote Similarity NPD2814 Clinical (unspecified phase)
0.6435 Remote Similarity NPD1600 Suspended
0.6435 Remote Similarity NPD3968 Approved
0.6429 Remote Similarity NPD6829 Phase 2
0.6426 Remote Similarity NPD8405 Clinical (unspecified phase)
0.6425 Remote Similarity NPD2127 Suspended
0.6419 Remote Similarity NPD6838 Clinical (unspecified phase)
0.6404 Remote Similarity NPD5426 Phase 3
0.6404 Remote Similarity NPD5901 Discontinued
0.64 Remote Similarity NPD7000 Clinical (unspecified phase)
0.64 Remote Similarity NPD6999 Discontinued
0.6382 Remote Similarity NPD3360 Clinical (unspecified phase)
0.6379 Remote Similarity NPD8013 Clinical (unspecified phase)
0.6376 Remote Similarity NPD2008 Discontinued
0.6368 Remote Similarity NPD2547 Discontinued
0.636 Remote Similarity NPD2803 Discontinued
0.6356 Remote Similarity NPD1623 Approved
0.6351 Remote Similarity NPD6665 Discontinued
0.6348 Remote Similarity NPD1506 Discontinued
0.6339 Remote Similarity NPD6449 Clinical (unspecified phase)
0.6329 Remote Similarity NPD5198 Approved
0.6329 Remote Similarity NPD5199 Approved
0.6325 Remote Similarity NPD8094 Discontinued
0.6323 Remote Similarity NPD1173 Approved
0.632 Remote Similarity NPD7666 Phase 3
0.632 Remote Similarity NPD7665 Phase 2
0.6318 Remote Similarity NPD6141 Clinical (unspecified phase)
0.6314 Remote Similarity NPD8256 Approved
0.6314 Remote Similarity NPD5643 Phase 2
0.6314 Remote Similarity NPD8257 Approved
0.6314 Remote Similarity NPD8258 Clinical (unspecified phase)
0.6314 Remote Similarity NPD2787 Clinical (unspecified phase)
0.631 Remote Similarity NPD4558 Phase 2
0.6304 Remote Similarity NPD7001 Phase 3
0.6304 Remote Similarity NPD3967 Approved
0.6293 Remote Similarity NPD2408 Discontinued
0.6293 Remote Similarity NPD5510 Approved
0.6292 Remote Similarity NPD7202 Clinical (unspecified phase)
0.6289 Remote Similarity NPD6458 Discontinued
0.6283 Remote Similarity NPD1982 Phase 1
0.6282 Remote Similarity NPD8097 Phase 3
0.6282 Remote Similarity NPD2411 Approved
0.6282 Remote Similarity NPD8096 Phase 3
0.6282 Remote Similarity NPD8093 Discontinued
0.6278 Remote Similarity NPD3406 Suspended
0.6272 Remote Similarity NPD7903 Clinical (unspecified phase)
0.627 Remote Similarity NPD8106 Phase 2
0.6266 Remote Similarity NPD7998 Clinical (unspecified phase)
0.6264 Remote Similarity NPD8349 Phase 1
0.6256 Remote Similarity NPD2405 Phase 3
0.6244 Remote Similarity NPD3486 Clinical (unspecified phase)
0.624 Remote Similarity NPD7603 Discontinued
0.624 Remote Similarity NPD3914 Clinical (unspecified phase)
0.624 Remote Similarity NPD8289 Discontinued
0.6233 Remote Similarity NPD6180 Clinical (unspecified phase)
0.6224 Remote Similarity NPD7717 Approved
0.6224 Remote Similarity NPD7716 Approved
0.6222 Remote Similarity NPD7619 Phase 3
0.6222 Remote Similarity NPD7618 Phase 3
0.622 Remote Similarity NPD7415 Suspended
0.6213 Remote Similarity NPD8458 Clinical (unspecified phase)
0.6205 Remote Similarity NPD4376 Phase 3
0.6202 Remote Similarity NPD276 Clinical (unspecified phase)
0.6199 Remote Similarity NPD5820 Clinical (unspecified phase)
0.6198 Remote Similarity NPD7269 Clinical (unspecified phase)
0.6194 Remote Similarity NPD6970 Phase 2
0.619 Remote Similarity NPD8169 Discontinued
0.619 Remote Similarity NPD6288 Clinical (unspecified phase)
0.619 Remote Similarity NPD8098 Approved
0.619 Remote Similarity NPD8272 Phase 2
0.6189 Remote Similarity NPD1571 Phase 2
0.6188 Remote Similarity NPD3870 Clinical (unspecified phase)
0.6188 Remote Similarity NPD3871 Clinical (unspecified phase)
0.6186 Remote Similarity NPD2823 Clinical (unspecified phase)
0.6186 Remote Similarity NPD8488 Clinical (unspecified phase)
0.6167 Remote Similarity NPD6210 Phase 3
0.6167 Remote Similarity NPD6664 Approved
0.6167 Remote Similarity NPD2880 Discontinued
0.6157 Remote Similarity NPD482 Approved
0.6157 Remote Similarity NPD4883 Approved
0.6157 Remote Similarity NPD5065 Approved
0.6157 Remote Similarity NPD6173 Approved
0.6154 Remote Similarity NPD5040 Clinical (unspecified phase)
0.6147 Remote Similarity NPD2121 Clinical (unspecified phase)
0.6144 Remote Similarity NPD7594 Clinical (unspecified phase)
0.614 Remote Similarity NPD3347 Clinical (unspecified phase)
0.6137 Remote Similarity NPD796 Phase 2
0.6136 Remote Similarity NPD2092 Phase 2
0.6136 Remote Similarity NPD2095 Phase 2
0.6136 Remote Similarity NPD2094 Phase 2
0.6136 Remote Similarity NPD7393 Clinical (unspecified phase)
0.6136 Remote Similarity NPD5728 Clinical (unspecified phase)
0.6132 Remote Similarity NPD5138 Approved
0.6132 Remote Similarity NPD5140 Approved
0.613 Remote Similarity NPD7817 Phase 1
0.6129 Remote Similarity NPD2367 Phase 2
0.6129 Remote Similarity NPD749 Clinical (unspecified phase)
0.6125 Remote Similarity NPD7168 Phase 3
0.6119 Remote Similarity NPD6595 Phase 3
0.6113 Remote Similarity NPD1572 Phase 2
0.6111 Remote Similarity NPD6376 Discontinued
0.6111 Remote Similarity NPD4612 Discontinued
0.6111 Remote Similarity NPD2509 Approved
0.6111 Remote Similarity NPD4960 Approved
0.6111 Remote Similarity NPD2510 Approved
0.6111 Remote Similarity NPD4959 Approved
0.6109 Remote Similarity NPD2096 Phase 2
0.6109 Remote Similarity NPD2091 Phase 2
0.6109 Remote Similarity NPD8406 Clinical (unspecified phase)
0.6107 Remote Similarity NPD5887 Clinical (unspecified phase)
0.6107 Remote Similarity NPD7711 Discontinued
0.6107 Remote Similarity NPD5461 Discontinued
0.6103 Remote Similarity NPD1568 Clinical (unspecified phase)
0.61 Remote Similarity NPD5827 Discontinued
0.6099 Remote Similarity NPD2009 Clinical (unspecified phase)
0.6099 Remote Similarity NPD3961 Discontinued
0.6096 Remote Similarity NPD5446 Phase 2
0.6094 Remote Similarity NPD6732 Clinical (unspecified phase)
0.6092 Remote Similarity NPD3757 Clinical (unspecified phase)
0.6091 Remote Similarity NPD6849 Phase 2
0.6091 Remote Similarity NPD6850 Phase 2
0.6087 Remote Similarity NPD484 Approved
0.6083 Remote Similarity NPD6578 Clinical (unspecified phase)
0.6083 Remote Similarity NPD6470 Phase 3
0.6081 Remote Similarity NPD6557 Phase 2
0.6079 Remote Similarity NPD4998 Phase 3
0.6079 Remote Similarity NPD5853 Phase 3
0.6079 Remote Similarity NPD5855 Phase 3
0.6079 Remote Similarity NPD4999 Phase 3
0.6076 Remote Similarity NPD4852 Phase 2
0.6073 Remote Similarity NPD5935 Discontinued
0.6071 Remote Similarity NPD6715 Discontinued
0.607 Remote Similarity NPD7204 Clinical (unspecified phase)
0.607 Remote Similarity NPD9076 Clinical (unspecified phase)
0.6068 Remote Similarity NPD6328 Clinical (unspecified phase)
0.6068 Remote Similarity NPD8410 Clinical (unspecified phase)
0.6062 Remote Similarity NPD6887 Clinical (unspecified phase)
0.6062 Remote Similarity NPD7098 Clinical (unspecified phase)
0.6058 Remote Similarity NPD5965 Clinical (unspecified phase)
0.6058 Remote Similarity NPD9343 Clinical (unspecified phase)
0.6058 Remote Similarity NPD7203 Clinical (unspecified phase)
0.6057 Remote Similarity NPD7781 Approved
0.6057 Remote Similarity NPD7780 Approved
0.6054 Remote Similarity NPD4426 Clinical (unspecified phase)
0.6052 Remote Similarity NPD3947 Discontinued
0.6052 Remote Similarity NPD944 Approved
0.6048 Remote Similarity NPD6263 Clinical (unspecified phase)
0.6047 Remote Similarity NPD7860 Clinical (unspecified phase)
0.6044 Remote Similarity NPD3439 Approved
0.6044 Remote Similarity NPD1043 Phase 3
0.6043 Remote Similarity NPD6137 Clinical (unspecified phase)
0.6043 Remote Similarity NPD6459 Phase 2
0.6043 Remote Similarity NPD5854 Approved
0.6034 Remote Similarity NPD6268 Phase 1
0.6034 Remote Similarity NPD7321 Clinical (unspecified phase)
0.6034 Remote Similarity NPD6269 Clinical (unspecified phase)
0.6032 Remote Similarity NPD1659 Phase 1
0.6031 Remote Similarity NPD5116 Phase 1
0.6027 Remote Similarity NPD6203 Clinical (unspecified phase)
0.6025 Remote Similarity NPD6481 Clinical (unspecified phase)
0.6019 Remote Similarity NPD4184 Clinical (unspecified phase)
0.6018 Remote Similarity NPD6022 Clinical (unspecified phase)
0.6017 Remote Similarity NPD6545 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data